{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:56:54Z","timestamp":1783702614176,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s00787-009-0075-y","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T18:27:55Z","timestamp":1257445675000},"page":"159-166","source":"Crossref","is-referenced-by-count":15,"title":["Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands"],"prefix":"10.1007","volume":"19","author":[{"given":"Adrianne","family":"Faber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luuk J.","family":"Kalverdijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lolkje T. W.","family":"de Jong-van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline G.","family":"Hugtenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud B.","family":"Minderaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Tobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,6]]},"reference":[{"key":"75_CR1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1067\/mpd.2001.111505","volume":"138","author":"P Accardo","year":"2001","unstructured":"Accardo P, Blondis TA (2001) What\u2019s all the fuss about Ritalin? J Pediatr 138:6\u20139","journal-title":"J Pediatr"},{"key":"75_CR2","doi-asserted-by":"crossref","first-page":"85S","DOI":"10.1097\/00004583-199710001-00007","volume":"36","author":"American Academy of Child and Adolescent Psychiatry","year":"1997","unstructured":"American Academy of Child and Adolescent Psychiatry (1997) Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36:85S\u2013121S","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"75_CR3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1542\/peds.108.4.1033","volume":"108","author":"American Academy of Pediatrics","year":"2001","unstructured":"American Academy of Pediatrics (2001) Clinical practice guideline: diagnosis an evaluation of the child with attention-deficit hyperactivity disorder. Pediatrics 108:1033\u20131044","journal-title":"Pediatrics"},{"key":"75_CR4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/104454601750143429","volume":"11","author":"M Boles","year":"2001","unstructured":"Boles M, Lynch FL, DeBar LL (2001) Variations in pharmacotherapy for attention deficit hyperactivity disorder in managed care. J Child Adolesc Psychopharmacol 11:43\u201352","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"75_CR5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4088\/JCP.v62n0405","volume":"62","author":"JK Buitelaar","year":"2001","unstructured":"Buitelaar JK, van der Gaag RJ, Cohen-Kettenis P et al (2001) A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry 62:239\u2013248","journal-title":"J Clin Psychiatry"},{"key":"75_CR6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s007870050083","volume":"8","author":"T Clark","year":"1999","unstructured":"Clark T, Feehan C, Tinline C et al (1999) Autistic symptoms in children with attention deficit-hyperactivity disorder. Eur Child Adolesc Psychiatry 8:50\u201355","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"Suppl 6","key":"75_CR7","first-page":"12","volume":"65","author":"M Delbello","year":"2004","unstructured":"Delbello M, Grcevich S (2004) Phenomenology and epidemiology of childhood psychiatric disorders that may necessitate treatment with atypical antipsychotics. J Clin Psychiatry 65(Suppl 6):12\u201319","journal-title":"J Clin Psychiatry"},{"key":"75_CR8","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.jclinepi.2005.03.007","volume":"58","author":"A Faber","year":"2005","unstructured":"Faber A, van den Berg LTW, Netjes KA et al (2005) Recruitment of parents and physicians of stimulant-using children via community pharmacies is successful. J Clin Epidemiol 58:1072\u20131073","journal-title":"J Clin Epidemiol"},{"key":"75_CR9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/cap.2006.16.432","volume":"16","author":"A Faber","year":"2006","unstructured":"Faber A, Kalverdijk LJ, Hugtenburg JG et al (2006) Parents report on stimulant-treated youths in the Netherlands: initiation and follow-up care. J Child Adolesc Psychopharmacol 16:432\u2013440","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"75_CR10","doi-asserted-by":"crossref","first-page":"I80","DOI":"10.1007\/s00787-004-1008-4","volume":"13","author":"C Gillberg","year":"2004","unstructured":"Gillberg C, Gillberg IC, Rasmussen P et al (2004) Co-existing disorders in ADHD\u2014implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 13:I80\u2013I92","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"75_CR11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1023\/B:JADD.0000029554.46570.68","volume":"34","author":"S Goldstein","year":"2004","unstructured":"Goldstein S, Schwebach AJ (2004) The co-morbidity of pervasive developmental disorder and attention deficit hyperactivity disorder: results of a retrospective chart review. J Autism Dev Disord 34:329\u2013339","journal-title":"J Autism Dev Disord"},{"key":"75_CR12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00004583-200002000-00020","volume":"39","author":"K Hoagwood","year":"2000","unstructured":"Hoagwood K, Kelleher KJ, Feil M et al (2000) Treatment services for children with ADHD: a national perspective. J Am Acad Child Adolesc Psychiatry 39:198\u2013206","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"75_CR13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00004583-200102000-00009","volume":"40","author":"PS Jensen","year":"2001","unstructured":"Jensen PS, Hinshaw SP, Kraemer HC (2001) ADHD co-morbidity findings from the MTA study: Comparing co-morbid subgroups. J Am Acad Child Adolesc Psychiatry 40:147\u2013158","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"75_CR14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0924-977X(03)00045-2","volume":"14","author":"S Kutcher","year":"2004","unstructured":"Kutcher S, Aman M, Brooks SJ et al (2004) International consensus statement on attention-deficit\/hyperactivity disorder (ADHD) and disruptive disorders (DBDs): clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol 14:11\u201328","journal-title":"Eur Neuropsychopharmacol"},{"key":"75_CR15","volume-title":"Pharmacoepidemiology","author":"HGM Leufkens","year":"2000","unstructured":"Leufkens HGM, Urquhart J (2000) Automated pharmacy record linkage in the Netherlands. In: Strom BL (ed) Pharmacoepidemiology, 3rd edn. Wiley, Chichester","edition":"3"},{"key":"75_CR16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s007870070040","volume":"9","author":"EF Luteijn","year":"2000","unstructured":"Luteijn EF, Serra M, Jackson S et al (2000) How unspecified are disorders of children with a pervasive developmental disorder not otherwise specified? A study of social problems in children with PDD-NOS and ADHD. Eur Child Adolesc Psychiatry 9:168\u2013179","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"75_CR17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1176\/appi.ps.54.1.72","volume":"54","author":"A Martin","year":"2003","unstructured":"Martin A, Van Hoof T, Stubbe D et al (2003) Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care. Psychiatr Serv 54:72\u201377","journal-title":"Psychiatr Serv"},{"key":"75_CR18","volume-title":"Child pathology","author":"EJ Mash","year":"2003","unstructured":"Mash EJ, Barkley RA (2003) Child pathology. The Guilford Press, New York"},{"key":"75_CR19","first-page":"1489","volume":"165","author":"AR Miller","year":"2001","unstructured":"Miller AR, Lalonde CE, McGrail KM et al (2001) Prescription of methylphenidate to children and youth, 1990\u20131996. Can Med Assoc J 165:1489\u20131494","journal-title":"Can Med Assoc J"},{"key":"75_CR20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00004583-200205000-00008","volume":"41","author":"M Olfson","year":"2002","unstructured":"Olfson M, Marcus SC, Weissman MM et al (2002) National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry 41:514\u2013521","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"75_CR21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/cap.2005.15.44","volume":"15","author":"M Radigan","year":"2005","unstructured":"Radigan M, Lannon P, Roohan P et al (2005) Medication patterns for attention-deficit\/hyperactivity disorder and co-morbid psychiatric conditions in a low-income population. J Child Adolesc Psychopharmacol 15:44\u201356","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"75_CR22","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/00004583-200208000-00008","volume":"41","author":"R Reid","year":"2002","unstructured":"Reid R, Hakendorf P, Prosser B (2002) Use of psychostimulant medication for ADHD in South Australia. J Am Acad Child Adolesc Psychiatry 41:906\u2013913","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"75_CR23","first-page":"1266","volume":"63","author":"Research Units on Pediatric Psychopharmacology Autism Network","year":"2005","unstructured":"Research Units on Pediatric Psychopharmacology Autism Network (2005) Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 63:1266\u20131274","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"75_CR24","first-page":"314","volume":"347","author":"Research Units on Pediatric Psychopharmacology Autism Network","year":"2001","unstructured":"Research Units on Pediatric Psychopharmacology Autism Network (2001) Risperidone in children with autism and serious behavioral problems. N Engl J Med 347(5):314\u2013321","journal-title":"N Engl J Med"},{"key":"75_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00004850-200401000-00003","volume":"19","author":"LM Robison","year":"2004","unstructured":"Robison LM, Sclar DA, Skaer TL et al (2004) Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder:1995\u201399. Int Clin Psychopharmacol 19:17\u201322","journal-title":"Int Clin Psychopharmacol"},{"key":"75_CR26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/10401230009147088","volume":"12","author":"DJ Safer","year":"2000","unstructured":"Safer DJ (2000) Are stimulants overprescribed for youths with ADHD? Ann Clin Psychiatry 12:55\u201362","journal-title":"Ann Clin Psychiatry"},{"key":"75_CR27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5694\/j.1326-5377.2002.tb04624.x","volume":"177","author":"MG Sawyer","year":"2002","unstructured":"Sawyer MG, Rey JM, Graetz BW et al (2002) Use of medication by young people with attention-deficit\/hyperactivity disorder. Med J Australia 177:21\u201325","journal-title":"Med J Australia"},{"key":"75_CR28","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1542\/peds.108.2.e25","volume":"108","author":"E Schirm","year":"2001","unstructured":"Schirm E, Tobi H, Zito JM et al (2001) Psychotropic medication in children: a study from the Netherlands. Pediatrics 108:e25","journal-title":"Pediatrics"},{"key":"75_CR29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00787-004-1002-x","volume":"13","author":"E Taylor","year":"2004","unstructured":"Taylor E, D\u00f6pfner M, Sergeant J et al (2004) European clinical guidelines for hyperkinetic disorder\u2014first upgrade. Eur Child Adolesc Psychiatry 13:7\u201330","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"75_CR30","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archpsyc.56.12.1073","volume":"56","author":"The MTA Cooperative Group","year":"1999","unstructured":"The MTA Cooperative Group (1999) A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder. Arch Gen Psychiatry 56:1073\u20131086","journal-title":"Arch Gen Psychiatry"},{"key":"75_CR31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00787-004-0391-1","volume":"13","author":"Y Yoshida","year":"2004","unstructured":"Yoshida Y, Uchiyama T (2004) The clinical necessity for assessing attention deficit\/hyperactivity disorder (AD\/HD) symptoms in children with high-functioning pervasive developmental disorder (PDD). Eur Child Adolesc Psychiatry 13:307\u2013314","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"75_CR32","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archpedi.153.12.1257","volume":"153","author":"JM Zito","year":"1999","unstructured":"Zito JM, Safer DJ, DosReis S et al (1999) Psychotropic medication patterns for youths with attention deficit hyperactivity disorder. Arch Pediatr Adolesc Med 153:1257\u20131263","journal-title":"Arch Pediatr Adolesc Med"},{"key":"75_CR33","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.283.8.1025","volume":"283","author":"JM Zito","year":"2000","unstructured":"Zito JM, Safer DJ, DosReis S et al (2000) Trends in the prescribing of psychotropic medications to preschoolers. JAMA 283:1025\u20131030","journal-title":"JAMA"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-009-0075-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T12:48:06Z","timestamp":1590238086000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00787-009-0075-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,6]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["75"],"URL":"https:\/\/doi.org\/10.1007\/s00787-009-0075-y","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,6]]}}}